Top Bio Pharmaceutical Companies in USA List by Market Cap as on July-30-2023

Bristol-Myers Squibb is USA based healthcare and pharmaceutical multi-national company.

 BMS is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

Company has over 32,200 employees as on 2021. Headquarters is in USA.

BMS discover, develop and deliver innovative medicines that help patients prevail over serious diseases

BMS be the world's leading biopharma company that transforms patients' lives through science.

Amgen main mission is to serve patients. Amgen is leader in Biotechnology industry, research and making Biotechnology Products. Company has over 22,000 employees as on 2020. Headquarters is in California, USA.

Amgen Prevents Infections in Cancer Patients Program to Launch Innovative Tools to Improve Patient-Provider Conversations

Amgen is dedicated to the fight against heart disease and has now launched Breakaway from Heart Disease™. The collective goal of this national campaign is to help make America’s heart health a priority.

Amgen believes in a “biology first” approach. Amgen use cutting-edge science and technology to study the subtlest biological mechanisms in search of therapies that will improve the lives of those who suffer from diseases. Amgen believes the cure for disease can be found inside each and every one of us.

GILEAD SCIENCES INC is world’s largest bio-pharmaceutical companies. As on Dec-2021, Gilead Sciences had 14,400 employees across six continents and headquarters is in USA,

As on 2022, GILEAD SCIENCES INC has 17,000 employees.

GILEAD SCIENCES INC annual revenue generated for period ending Dec-2022 was 27,281 million USD.

GILEAD SCIENCES INC annual net loss generated for period ending Dec-2022 was 4,592 million USD.

VERTEX PHARMACEUTICALS is USA Based Bio-Technology, Bio-Pharmaceutical and Healthcare Company.It have research and development sites, manufacturing facilities and offices around the world. The company locations are North America, Europe, Australia, South America.

As on 2022, VERTEX PHARMACEUTICALS has 4,500 employees.

VERTEX PHARMACEUTICALS annual revenue generated for period ending Dec-2022 was 8,930 million USD.

VERTEX PHARMACEUTICALS annual net income generated for period ending Dec-2022 was 3,322 million USD.

VERTEX PHARMACEUTICALS annual revenue generated for period ending Dec-2021 was 7,574 million USD.

Split of Annual Revenue by business segment  for period ending Dec-2021:

REGENERON PHARMACEUTICALS is Bio-Pharmaceutical company with headquarters in New York, USA.

As on 2022, REGENERON PHARMACEUTICALS has 11,851 employees.

REGENERON PHARMACEUTICALS annual revenue generated for period ending Dec-2022 was 12,172 million USD.

REGENERON PHARMACEUTICALS annual net income generated for period ending Dec-2022 was 4,338 million USD.

As on 2020, they had 9,123 employees. They had 7 FDA approved medicines.

Moderna is Biotechnology sector company with headquarters in Massachusetts, USA. It is working actively to find Covid-19 vaccine.

As on 2022, Moderna has 3,900 employees.

Moderna annual revenue generated for period ending Dec-2022 was 18.87 billion USD.

Moderna annual net income generated for period ending Dec-2022 was 8.36 billion USD.

As on 2019, Moderna has  830, a 9.21% increase from 2018. Moderna total number of employees in 2018 was 760, a 11.76% increase from 2017.

Moderna annual revenue generated for period ending Dec-2021 was 16,471 million USD.

Moderna annual net income generated for period ending Dec-2021 was 12,202 million USD.

Total Assets as on Dec-2021 was 24,669 Million USD.

ALNYLAM PHARMACEUTICALS is Biopharmaceutical company with headquarters in Massachusetts, USA.ALNYLAM  leaders from the biopharmaceutical industry, bringing together their experiences of drug discovery, drug development, and commercialization.Alnylam has led the translation of RNAi (RNA interference) from Nobel Prize-winning discovery into an innovative, entirely new class of medicines.

ALNYLAM PHARMACEUTICALS was NEW CLINICAL PROGRAMS ADDED IN 2021 and 2.4 BILLION IN CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES AT YEAR-END 2021.

As on 2022, ALNYLAM PHARMACEUTICALS has 2,002 employees.

ALNYLAM PHARMACEUTICALS annual revenue generated for period ending Dec-2022 was 1,037 million USD.

ALNYLAM PHARMACEUTICALS annual net loss generated for period ending Dec-2022 was -1,131 (Loss) million USD.

Incyte Corporation is a Bio-Pharmaceutical company with headquarters in Delaware, USA.

As on 2021, Incyte Corporation has 2,094 employees, 989 are in research and development, 187 in medical affairs, 638 in sales and marketing and 280 in operations support, finance and administrative positions.

As on 2022, Incyte Corporation has 2,324 employees.

Incyte Corporation annual revenue generated for period ending Dec-2022 was 3,394 million USD.

Incyte Corporation annual net income generated for period ending Dec-2022 was 340 million USD.

Neurocrine Biosciences is a Neuroscience Focused and Biopharmaceutical company. It is discovering and developing life-changing treatments for people with serious, challenging, under addressed neurological, endocrine and psychiatric disorders. The headquarters is in USA.